Risk Stratification in Older Intensively Treated Patients With AML.
Versluis J. et al, (2024), J Clin Oncol
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
Sheppard JP. et al, (2024), The Lancet Healthy Longevity, 5, e563 - e573
Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
SHEPPARD J. et al, (2024), The Lancet Healthy Longevity
EFFECT OF ANTIHYPERTENSIVE DEPRESCRIBING ON SERIOUS ADVERSE EVENTS, MORTALITY, AND CARDIOVASCULAR DISEASE: LONG-TERM FOLLOW-UP OF THE OPTIMISE RANDOMISED CONTROLLED TRIAL
Sheppard J. et al, (2024), Journal of Hypertension, 42, e109 - e110
PREDITING THE RISK OF FRACTURE ASSOCIATED WITH ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT OF THE STRATIFY-FRACTURE PREDICTION MODEL
Wang A. et al, (2023), JOURNAL OF HYPERTENSION, 41, E3 - E3
Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study.
Maredza M. et al, (2022), Br J Ophthalmol, 106, 1549 - 1554
Mechanisms and contextual influences on the implementation of advance care planning for older people in long-term care facilities: A realist review
Zhou Y. et al, (2022), International Journal of Nursing Studies, 104277 - 104277
Identifying risk factors of monoclonal gammopathy of undetermined significance (MGUS): a population-based study using data from the UK clinical practice research datalink (CPRD)
Koshiaris C. et al, (2022), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, S131 - S131
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): statistical analysis plan for a randomised controlled trial assessing the effectiveness of peri-articular liposomal bupivacaine plus bupivacaine hydrochloride compared with bupivacaine hydrochloride alone
Stokes JR. et al, (2021), Trials, 22
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
Hinks TSC. et al, (2021), The Lancet Respiratory Medicine, 9, 1130 - 1140
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study (vol 128, pg 561, 2021)
Lois N. et al, (2021), OPHTHALMOLOGY, 128, 1117 - 1117
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study
Lois N. et al, (2021), Health technology assessment (Winchester, England), 25, 1 - 104
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study
Lois N. et al, (2021), Ophthalmology, 128, 561 - 573
A RANDOMISED CLINICAL TRIAL OF AZITHROMYCIN VERSUS STANDARD CARE IN AMBULATORY COVID-19-THE ATOMIC2 TRIAL
Hinks TSC. et al, (2021), THORAX, 76, A35 - A35